Atrium Therapeutics
The Senior Director, Program Management provides strategic and operational leadership for Atrium’s cross-functional drug development programs, partnering with functional leaders to shape strategy and drive execution from early development through clinical and regulatory milestones. This high-impact role requires deep drug development experience and the ability to lead through influence in a fast-paced, matrixed biotech environment. The position involves managing integrated plans, identifying risks, and leveraging AI-enabled tools to improve operational efficiency and decision-making.
Our vision is to pioneer precision RNA medicines for the heart and profoundly improve the lives of people impacted by cardiac diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Atrium Therapeutics.
CMC Program Lead
Telix Pharmaceuticals
Senior Director of Program Management
Viking Therapeutics
Senior Director, Clinical Research Oncology Program Executive (PE)
Vir Biotechnology
Sr. Clinical Program Manager
Neurocrine Biosciences
Senior Medical Director – Accelerated R&D Leadership Program
Eli Lilly and Company
Associate Director, Program Management – Orexin Development Programs
Centessa Pharmaceuticals